Anti-coagulant [EPC]

5893 reported adverse events

Drugs of this class: ASPIRIN, CITRIC ACID, SODIUM BICARBONATE BIVALIRUDIN ARGATROBAN ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SODIUM CITRATE AND CITRIC ACID MONOHYDRATE ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) ADENOSINUM TRIPHOSPHORICUM DINATRUM, NADIDUM, ARGENTUM NITRICUM, IPECACUANHA, ROBINIA PSEUDOACACIA, SULPHUR, ORIGANUM VULGARE, DUODENUM (SUIS), ESOPHAGUS (SUIS), FUNICULUS UMBILICALIS SUIS, STOMACH (SUIS), NUX VOMICA, COUMARINUM, ERYTHRAEA CENTAURIUM, PANCREATINUM, MURIATICUM ACIDUM, CITRICUM ACIDUM, FORMICUM ACIDUM, SARCOLACTICUM ACIDUM, COENZYME A, PROTEUS (MORGANI) ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE

These side effects are most commonly reported by patients taking drugs of the Anti-coagulant [EPC] class:

#	Side effect	Count
0	CHRONIC KIDNEY DISEASE	730
1	ACUTE KIDNEY INJURY	474
2	RENAL FAILURE	471
3	DRUG INEFFECTIVE	420
4	OFF LABEL USE	291
5	THROMBOSIS IN DEVICE	291
6	HAEMORRHAGE	288
7	END STAGE RENAL DISEASE	260
8	THROMBOSIS	240
9	HEPARIN-INDUCED THROMBOCYTOPENIA	232

See all common reactions for Anti-coagulant [EPC]

Drugs of the Anti-coagulant [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	COAGULATION TIME ABNORMAL	128	0.5039
1	CORONARY ARTERY PERFORATION	29	0.2685
2	STENT OCCLUSION	97	0.1823
3	REPERFUSION INJURY	17	0.1466
4	CORONARY ARTERY THROMBOSIS	199	0.1092
5	CORONARY REVASCULARISATION	14	0.0986
6	THROMBOSIS IN DEVICE	291	0.0926
7	CARDIAC PROCEDURE COMPLICATION	43	0.0789
8	COAGULATION TIME PROLONGED	107	0.0779
9	COAGULATION TIME SHORTENED	18	0.0581

See all enriched reactions for Anti-coagulant [EPC]